“Despite much variation in their methodologies, these studies broadly agreed that schizophrenic groups' use of amphetamines and cocaine, cannabis, hallucinogens, inhalants, caffeine , and tobacco was significantly greater than or equal to use by control groups consisting of other psychiatric patients or normal subjects.”